FY4/23
IR PRESENTATION

June 2023

Results Overview© 2023 AIN HOLDINGS INC. All Rights Reserved.

1

Consolidated P/L
Net sales increased 13.4% YoY and 0.2% against the plan due to new store openings and contributionof existing stores, despite the impact of the COVID-19. Ordinary profit increased 6.4% YoY anddeclined 5.4% against the plan due to increase of sales.

FY4/23
revised plan

Net sales

316,247

358,000

358,742 ＋42,495 ＋13.4＋0.2

Gross profit

49,97154,87053,698

15.8

15.3

15.0

34,832

37,69037,694

11.0

10.5

10.5

15,13917,18016,004

4.8

4.8

4.5

16,041

18,03017,064

5.1

5.0

4.8

7,092

9,000

9,234

% of net sales

2.2

2.5

2.6

Earnings per
share(¥)

201.47256.20262.87（¥ million）% of net sales

SG&A expenses% of net sales

Operating profit% of net sales

Ordinary profit% of net sales

Profit attributable toowners of parent

FY4/23
results

YoYchangeFY4/22
results

YoYchange(%)

Vs plan(%)＋3,727

＋7.5

(2.1)

＋2,862

＋8.2

＋0.0

＋865

＋5.7

(6.8)

＋1,023

＋6.4

(5.4)

＋2,142

＋30.2

＋2.6

＋61.40

＋30.5

＋2.6

Figures in the table are rounded down
© 2023 AIN HOLDINGS INC. All Rights Reserved.

2

Dispensing Pharmacy Business (Consolidated)
Net sales increased 13.6% YoY and 0.0% against the plan due to new store openings including M&A
and contribution of stores opened previous year. Segment profit declined 3.8% YoY and 5.4%
against the plan.

（¥ million）

FY4/23
revised plan

Net sales

283,111

321,560

321,577 ＋38,466 ＋13.6＋0.0

Gross profit

38,19441,35039,779＋1,585

＋4.1

(3.8)

13,875

16,62016,559＋2,684 ＋19.3(0.4)

24,31924,73023,220(1,099)

(4.5)

(6.1)

25,082

25,52024,135

(947)

(3.8)

(5.4)

1,099

1,210

1,209

＋110 ＋10.0(0.1)% of net sales

SG&A expenses% of net sales

Operating profit% of net sales

Segment profit% of net sales

13.5
4.9

Number ofpharmacies

8.6
8.9

12.9
5.2
7.7
7.9

FY4/23
results

YoYchangeFY4/22
results

YoYchange(%)

Vs plan
(%)

12.4
5.1
7.2
7.5

Figures in the table are rounded down

© 2023 AIN HOLDINGS INC. All Rights Reserved.

3

Cosmetic and Drug Store Business (Consolidated)
Net sales increased 24.9% YoY and 3.1% against the plan due to the recovery of existing stores,
contribution of stores opened in previous year, and success of cost optimization despite the impactof the COVID-19. Segment profit was 38% against the plan, ¥2,978 million above the plan.
YoY
Change（¥ million）

Net sales

20,55824,92025,685＋5,127 ＋24.9＋3.1

Gross profit

7,030

9,410

9,694

＋2,664 ＋37.9

＋3.0

8,858

8,570

8,521

(337)

(1,827)

840

1,172

＋2,999- ＋39.5(1,764)

880

1,214

＋2,978- ＋38.0

78

78

78

0

% of net sales

34.2

SG&A expenses% of net sales

Operating profit% of net sales

Segment profit% of net sales

FY4/23
revised plan

FY4/23
results

FY4/22
results

43.1

Number ofstores

-

37.8
34.4
3.4
3.5

YoY
change(%)

Vs plan
(%)

37.7

(3.8)

(0.6)

33.2
4.6
4.7

0.0

0.0

Figures in the table are rounded down

© 2023 AIN HOLDINGS INC. All Rights Reserved.

4

Consolidated B/S
Net cash became ¥37,804 million and shareholders’ equity ratio became 54.6%. We are
maintaining a sound financial structure.
End-FY4/22
AssetsCurrent assets
Cash on handand in banks

Fixed assets
Goodwill

Liabilities

100,765

59,729111,696

36,352

Deferred
assetsTotal assets

End-FY4/23(¥ million)

AssetsCurrent assets

Current
liabilities

81,805

2,643

Cash on handand in banks

Long-term
liabilities

11,645

Fixed assets

Short-term debt

5,815

Goodwill- Total net assets 119,010

Deferred
assetsLong-term debt

Total liabilities

212,461 and net assets 212,461

Net cash
Shareholders’ equity
ratio(%)

51,03056.0

Total assets(¥ million)

Liabilities

98,305

46,796

133,444

46,443Current
liabilities

92,986Long-term
liabilities

12,218

Short-term debt

Long-term debt

3,670

5,021

- Total net assets 126,546
Total liabilities

231,750 and net assets 231,750

Net cash
Shareholders’ equity
ratio(%)

37,804
54.6

Figures in the table are rounded down
Net cash = Cash on hand and in banks – Interest-bearing debt
© 2023 AIN HOLDINGS INC. All Rights Reserved.

5

Assets
The balance of total assets increased ¥19,289 million from the end of the previous fiscal year
due to decrease of cash on hand and in banks and increase of inventories and goodwill.
(¥ million)
Cash on hand and in banks
Notes and accounts receivable
Inventories
Total current assets
Buildings and structures, net
Land
Total property, plant andequipment
Goodwill
Total intangible fixed assets
Investments in securities
Deferred tax assets
Deposits and guarantees
Total investments and other assets
Total fixed assets
Total deferred assets
Total assets

Figures in the table are rounded down

End-FY4/21

55,271
13,475
14,28596,398
16,270
10,390End-FY4/22

59,729
10,11014,790100,765
17,512
8,581

End-FY4/23

46,796
13,24921,58698,305
21,407
10,602

Change(12,933)＋3,139＋6,796(2,460)＋3,895＋2,02130,22930,63639,459＋8,82339,05742,666
2,697
4,415
20,31934,368107,264
203,662

36,352
41,2192,503
5,319
22,78539,840111,696
212,461

46,44352,343
2,720
5,990
24,50741,641
133,444
231,750＋10,091＋11,124＋217＋671＋1,722＋1,801＋21,748＋19,289

Change:End-FY4/23 compared with End-FY4/22

Capital expenditures (Property, plant and equipment and intangible fixed assets + Deposits and guarantees) totaled ¥14,756 million© 2023 AIN HOLDINGS INC. All Rights Reserved.

6

Liabilities and Net Assets
Accounts payable increased ¥7,942 million due to new store openings including M&A. Shortterm and long-term debt increased ¥233 million.
(¥ million)
Accounts payable
Short-term debt

End-FY4/21

46,758
3,670

End-FY4/22

50,756
2,643

End-FY4/23

58,6983,670

Change＋7,942＋1,027

74,16081,80592,986＋11,181

8,297

5,815

5,021

(794)

Total long-term liabilities

13,664

11,645

12,218＋573

Total liabilities

87,82593,450105,204＋11,754

Common stock

Total shareholders’ equity

21,89420,50073,506
115,899

21,89420,50078,661
119,038

21,89420,50485,963
126,362＋4＋7,302＋7,324

Total net assets

115,837

119,010

126,546＋7,536

Total liabilities and net assets

203,662

212,461

231,750＋19,289

Total current liabilities
Long-term debt

Capital surplus
Retained earnings

Figures in the table are rounded down
Change:End-FY4/23 compared with End-FY4/22© 2023 AIN HOLDINGS INC. All Rights Reserved.

7

Consolidated C/F
Decrease of Net cash used in investing activities expanded to ¥22,292 million due to large-scale
M&A. Cash and cash equivalents at the end of the year are still ample, despite decrease of ¥13,253
million from the previous fiscal year.
(¥ million)

FY4/22

Net cash provided by operating activities

26,156

20,267(5,889)13,125

15,882＋2,757

Depreciation and amortization

4,792

5,529

＋737

Amortization of goodwill

4,133

4,310

＋177

Decrease in accounts receivable

4,111

795

(3,316)(Increase) decrease in inventories(171)(4,948)(4,777)(2,376)

1,007＋3,383

3,235

3,013

(222)

(13,943)(22,292)(8,349)(8,416)(12,155)(3,739)(2,322)(14,614)(12,292)(7,753)(11,237)(3,484)

4,460(13,262)(17,722)59,470(46,217)(13,253)

Profit before income taxes

Increase (decrease) in other accounts receivable
Increase (decrease) in accounts payable
Net cash used in investing activities
Payments for purchases of property, plantand equipment and intangible fixed assets
Purchase of subsidiaries’ shares resulting
in obtaining controls
Net cash provided by financing activities
Net increase in cash and cash equivalents
Cash and cash equivalents at end of the year
© 2023 AIN HOLDINGS INC. All Rights Reserved.

FY4/23

Change8

Business Value Analysis
Shareholders’ equity ratio (%)
Market value equity ratio (%)
PER (times)
EPS (¥)PBR (times)
BPS (¥)ROA (%)ROE (%)EBITDA (¥ million)
EV/EBITDA (times)
Net D/E ratio (times)
Net cash (¥ million)
Shareholders’ value (¥ million)
Market capitalization (¥ million)
Figures in the table are rounded down

FY4/21

56.8
105.6
32.11
189.04
1.86
3,267.49
3.4
5.9
19,6128.80(0.37)
43,303
215,710215,043

FY4/22

56.0
96.6
28.99
201.471.74
3,385.51
3.4
6.0
24,065
6.54(0.43)
51,030208,305
205,143

FY4/23

54.6
85.5
21.46
262.87
1.58
3,599.47
4.2
7.5
25,8436.34(0.30)
37,804
201,720
198,133

Change(1.4)(11.1)(7.53)＋61.40(0.16)＋213.96＋0.8＋1.5＋1,778(0.20)＋0.13(13,226)(6,585)(7,010)Change：FY4/23 compared with FY4/22

Net D/E ratio =Net interest-bearing debt (Interest-bearing debt – Cash on hand and in banks) / Shareholders’ equity

Net cash = Cash on hand and in banks – Interest-bearing debt
Shareholders’ value = EV – Net interest-bearing debt
Market capitalization：Treasury stock is excepted
Share prices used to calculate market capitalization:
End-FY4/21 ¥6,070 (End-Apr,2021), End-FY4/22 ¥5,840 (End-Apr,2022), End-FY4/23 ¥5,640 (End-Apr,2023).
© 2023 AIN HOLDINGS INC. All Rights Reserved.

9

FY4/24 Plan (Consolidated)
The group forecasts net sales for the fiscal year ending April 30, 2024 increase 4.5% YoY due to our plans toopen 50 dispensing pharmacies and 12 cosmetic and drugstores. Ordinary profit will decrease 4.5% due to rising
prices, increase in costs of DX investment and proceeding with human capital management.
（¥ million）

Net sales

316,247

358,742

375,000 ＋16,258＋4.5

Gross profit

49,971

53,69855,413＋1,715＋3.2

34,832

37,69439,750＋2,056＋5.5

15,13916,004

15,663

(341)

(2.1)

16,041

17,06416,302

(762)

(4.5)

7,092

9,234

8,250

(984)

(10.7)% of net sales

2.2

2.6

2.2

Earnings per
share(¥)

201.47262.87234.84(28.03)(10.7)

55.00

60.00

60.00

0

0.0

% of net sales

SG&A expenses% of net sales

Operating profit% of net sales

Ordinary profit% of net sales

Profit attributable toowners of parent

Annual dividend (¥)

15.8
11.0
4.8
5.1

FY4/23
results

FY4/24
plan

YoY
ChangeFY4/22
results

15.0
10.5
4.5
4.8

YoY
change(%)

14.8
10.6
4.2
4.3

Figures in the table are rounded down
© 2023 AIN HOLDINGS INC. All Rights Reserved.

10

Review© 2023 AIN HOLDINGS INC. All Rights Reserved.

11

Review (YoY)
Ordinary profit increased ¥1.0 billion due to increase of net sales in dispensing pharmacy
business and cosmetic and drugstore business, etc.
Net sales

Ordinary profit¥358.7 billion +¥42.5 billion¥316.2 billion

Dispensing
Pharmacy¥283.1 billion+13.4%

Dispensing
Pharmacy¥321.6 billion■Dispensing
Pharmacy+¥38.5 billion■Cosmetic andDrug store+¥5.1 billion¥16.0 billion

Dispensing
Pharmacy

FY4/22

FY4/23© 2023 AIN HOLDINGS INC. All Rights Reserved.

Dispensing
Pharmacy¥(1.7) billion

Administrative
expense¥(7.2) billion

FY4/22+6.4%■Dispensing
Pharmacy

decrease of grossprofit, etc￥(0.9)billion

Drug store,
OthersCosmetic and Drug Store¥1.2billion
Others ¥0.1 billion
Cosmetic and Drug Store+¥1.0 billion¥24.1 billion ■Cosmetic and¥25.0 billion

Others ¥(0.1) billion■Retail shop,
OthersCosmetic and Drug Cosmetic and DrugStore ¥20.5 billion Store ¥25.6 billion¥(1.1) billion
Others ¥12.6 billion Others ¥11.5 billion¥17.0 billion

Administrative
expense¥(8.4) billion

Revenue,cost optimization,etc+¥3.1 billion

Administrative
expense,Others¥(1.2) billion

FY4/23

Decrease against profit：▲

DX investment¥(0.9) billion
Advertising costs¥(0.3) billion
12

Review (Revised plan)
Net sales increased ¥0.7 billion due to decrease of gross profit in dispensing pharmacy
business. Ordinary profit decreased 1.0billion.
Net sales

Ordinary profit¥358.0 billion ¥358.7 billion+¥0.7 billion+0.2%

Dispensing
Pharmacy

Dispensing
Pharmacy¥321.5 billion ¥321.5 billion■ Retail shop+¥0.7 billion
Cosmetic and Drug Store Cosmetic and Drug Store¥24.9billion¥25.6 billion
Others ¥11.5 billion
Others ¥11.5 billion

FY4/23
Plan

FY4/23Result© 2023 AIN HOLDINGS INC. All Rights Reserved.

＋¥(1.0) billion+(5.4)%¥18.0 billion■Dispensing¥17.0 billion Pharmacy

Dispensing
Pharmacy

Dispensing
Pharmacy¥25.5 billion¥24.1 billion

Cosmetic and Drug Store¥0.8 billion
Others ¥0billion

Cosmetic and Drug Store¥1.2billion
Others ¥0.1 billion

Administrative
expense¥(8.3) billion

Administrative
expense¥(8.4) billion

FY4/23

FY4/23Resultdecrease of grossprofit, etc.
¥(1.4)billion■Cosmetic andDrug store,
Otherscost optimization, etc+¥0.5 billion

Administrative
expense,Others¥(0.1) billion

Decrease against profit：▲
13

Strategy© 2023 AIN HOLDINGS INC. All Rights Reserved.

14

Strategy
Expansion of top-line and increase profits■Dispensing Pharmacy

Plan to open 50 pharmacies（Organic 30, M&A 20）■Cosmetic and Drug Store

Plan to open 12 stores

Recruiting and training of human resources■Planning to hire 650 newly graduated pharmacists and 400 medical staff■Make Field Manager system and Medical Supervisor system more established■Training of human resources

Reinforcing the Group’s business base
■Improving the customer services by promoting DX, such as official apps
■Promoting Sustainable Management

Turnaround and expansion of AINZ&TULPE■Opening stores in prime locations and medium and long term plans to open new stores© 2023 AIN HOLDINGS INC. All Rights Reserved.

15

Expansion of top-line and increase profits■Dispensing Pharmacy

Plan to open 50 pharmacies（Organic 30, M&A 20）■Cosmetic and Drug Store

Plan to open 12 stores■ Top-line¥316.2 billion +13.4%¥358.7 billion■Dispensing Pharmacy¥283.1 billion■Cosmetic and Drug store ¥20.5 billion■Others¥321.5 billion¥25.7 billion¥11.5 billion¥336.1 billion¥27.2 billion¥11.7 billion

283.1

321.5

336.1

20.5

25.7

27.2

FY4/22

FY4/23

FY4/24 (Plan)¥12.6 billion

400.0(¥billion)

Net sales

300.0
200.0
100.0
0.0

■ Profits¥16.0 billion■Dispensing Pharmacy■Cosmetic and Drug store■Others■Administrative cost

30.0

Ordinary profit(¥billion)

20.0
10.0
0.0

-10.0

+4.5% ¥375.0 billion+6.4% ¥17.0 billion(4.5)％ ¥16.3 billion¥24.1 billion¥1.2 billion¥0.1 billion¥(8.4) billion¥24.2 billion¥1.3 billion¥0 billion¥(9.2) billion¥25.0 billion¥(1.7) billion¥(0.1) billion¥(7.2) billion

130

25.0

24.1

24.2

-1.7
-7.2

1.2
-8.4

1.3
-9.2

FY4/22

FY4/23

FY4/24 (Plan)© 2023 AIN HOLDINGS INC. All Rights Reserved.

16

Expansion of top-line and increase profits■Dispensing Pharmacy

Plan to open 50 pharmacies（Organic 30, M&A 20）■Cosmetic and Drug Store

Plan to open 12 stores

FY4/23 Results

11018

FY4/24 Plan

1,287

Dispensing
Pharmacies
Cosmetics andDrug stores

1,209
78

Dispensing
Pharmacies
Cosmetics andDrug stores

157
1

65
7

:Dispensing Pharmacies

1,337

139
7

1,249

165
1

88

217
2

357
42

：Cosmetic and drug stores© 2023 AIN HOLDINGS INC. All Rights Reserved.

17

Expansion of top-line and increase profits■Dispensing Pharmacy

Plan to open 50 pharmacies（Organic 30, M&A 20）■Cosmetic and Drug Store

Plan to open 12 stores■ PlanFY4/24

Opening

FY4/23
Revised Plan

Results

Dispensing Pharmacy

141

141

50

Organic

27

27

30

M&A

114

114

20

8

8

12

149

149

62

30
8

31
8

10

38

39

12

Cosmetic and drug store
Total

ClosureDispensing Pharmacy
Cosmetic and drug store
Total

Plan

2

■ Transition of dispensing pharmacies
Organic
M&A

EV/EBITDA ratio

ClosedSold

No. of total stores

FY4/17

FY4/18

FY4/19FY4/20FY4/21

FY4/22

FY4/23

27

25

23

14

15

25

27

182
5.50
24
2
1,066

11
3.96
73
32
1,029

134
4.88
54
30
1,132

6
3.71
64
42
1,088

14
3.74
52
34
1,065

24
4.13
15
5
1,099

114
6.55
31
7
1,209

EV/EBITDA ratio=EV(Purchase price)/EBITDA(Operating income + Depreciation and amortization)© 2023 AIN HOLDINGS INC. All Rights Reserved.

18

Recruiting and training of human resources■Planning to hire 650 newly graduated pharmacists and 400 medical staff■Make Field Manager system and Medical Supervisor system more established■Training of human resources

In April 2023, new 543 pharmacists has joined our group. We aim to hire, new 650
pharmacists in fiscal 2024. As of April 30,2023, the group has 6,331 pharmacists out of
14,147 employees.
（People）

Pharmacists

Medical staffs
4,547

4,099

600

4,742

5,000
4,000

400
200

5,004

No. of student applications
5,267
5,234

257

163

660

613

560
215

240

543

3,000

650
346

213

400

2,000

No. of student
applications

No. of newly hired
students

800（People）
6,000

1,000
0

0

2019

© 2023 AIN HOLDINGS INC. All Rights Reserved.

2020

2021

2022

2023

2024 （Plan）（Year）

19

Reinforcing the Group’s business base

■Improving the customer services by promoting DX, such as official apps
■Promoting Sustainable Management
We have conducted our corporate activities with common sense and ethics in order to realize our groupstatement of “the health and happiness of our customers" through our businesses contributing to people's
health and beauty. Going forward, we will achieve sustainable corporate growth, create social, environmental,
and economic value, and realize sustainable management by changing and acting on our own initiative,
considering our customers and other diverse stakeholders.

1.Contribute to local healthcare

Pharmacies contributing to medical care that "treats
and supports in the entire community”

3.Safety, peace of mind
and trust
Delivering safety, peace ofmind, and trust through daily
operations
Preamble“realize the human rights of all”

2.Provide beauty and happiness
Providing beauty and happiness to enjoy
daily life in today's society

5.Ensure sound management
base

Strengthen a sound management basePreamble“realize the human rights of all”

4.Protect theenvironment and reduce
environmental impact
Contribute to environmental
protection and load reduction

6.Cooperate with local
communities and businesses
Promoting a healthy society andsustainability activities with local
communities and supply chains© 2023 AIN HOLDINGS INC. All Rights Reserved.

20

Reinforcing the Group’s business base

■Improving the customer services by promoting DX, such as official apps
■Promoting Sustainable Management
Sustainability Committee has been established across departments and positions
within our company, and approximately 30 project teams are promoting crosssectoral initiatives for each materiality.
1.Contribute to local healthcare

BCM（Business Continuity Management）

We have formulated an Evacuation
Model based on the assumption ofa major earthquake and conduct
evacuation drills at all ourpharmacies. We establish a system
to protect the safety of patientsand employees and ensure thecontinuous provision of medical
services.

New Human Resources System
We established our new humanresources system, which support
employee’s independence, growth,and diverse human resource
activities based on our corporate
philosophy (New Ain Statement),and has been in operation since
FY24/4.

© 2023 AIN HOLDINGS INC. All Rights Reserved.

6.Cooperate with local communities and businesses

CSR Procurement Policies

In September 2022, weformulated draft CSR
procurement policies.
We inform partners to holdour information seminar andengaged in problems likehuman rights, work, andenvironmental consideration.
5.Ensure sound management base

Outstanding Health and Productivity

In March 2023, the Group received
certification as an Outstanding
Health and Productivity
Management Organization for 2023
by Nippon Kenko Kaigi.
This certification recognizes leading
companies in health andproductivity management.
21

Turnaround and expansion of AINZ&TULPE■Opening stores in prime locations and medium and long term plans to open new stores

AINZ & TULPE
opened in FY4/23

8

storesCELEO KOKUBUNJI(Mar. 2023 ）HOKKAIDO BALL PARK
(Mar. 2023 ）KOBE MOTOMACHI（Jun. 2022）

FUTAKOTAMAGAWA RISE S.C（Oct. 2022）© 2023 AIN HOLDINGS INC. All Rights Reserved.

SAPPORO STELLA PLACE（Oct. 2022）
22

Turnaround and expansion of AINZ&TULPE■Opening stores in prime locations and medium and long term plans to open new stores

AINZ & TULPE
plan to open in FY4/24

12

stores(Tentative) COCONO SUSUKINO(Plan to open in Nov. 2023 )Tokyo(Plan to open in Feb. 2024 )Kanagawa（ Plan to open in Sep. 2023 ）© 2023 AIN HOLDINGS INC. All Rights Reserved.

COCORIA TAMA CENTER(Plan to open in Jun. 2023 ）23

FY4/24 Plan Dispensing Pharmacy Business
The group forecasts net sales for the fiscal year ending April 30, 2024 increase 4.5% YoY due toour plans to open 50 dispensing pharmacies and close 10 dispensing pharmacies. Segment profit
will increase 0.6%.

YoYchange（¥ million）

FY4/22
results

FY4/23
results

FY4/24plan

Net sales

283,111

321,577

336,093 ＋14,516＋4.5

Gross profit

38,194

39,77940,713＋934＋2.3

13,875

16,55917,080＋521＋3.1

24,31923,22023,633＋413＋1.8

25,082

24,13524,283

＋148

＋0.6

1,099

1,209

1,249

＋40

＋3.3

% of net sales

SG&A expenses% of net sales

Operating profit% of net sales

Segment profit% of net sales

13.5
4.9

Number ofpharmacies

8.6
8.9

12.4
5.1
7.2
7.5

YoY
change(%)

12.1
5.1
7.0
7.2

Figures in the table are rounded down
Segment profit is adjusted to ordinary profit in the consolidated statements of income.

© 2023 AIN HOLDINGS INC. All Rights Reserved.

24

FY4/24 Plan Cosmetic and Drug Store Business
The group forecasts net sales for the fiscal year ending April 30, 2024 increase 6.1% YoY due toour plans to open 12 cosmetic and drugstores and close 2 cosmetic and drugstores . Segment
profit will increase 12.9%.

（¥ million）

FY4/22
results

FY4/23
results

FY4/24plan

YoYchangeNet sales

20,55825,68527,263＋1,578＋6.1

Gross profit

7,030

9,694

10,405

＋711

＋7.3

8,858

8,521

9,035

＋514

＋6.0

(1,827)

1,172

1,370

＋198 ＋16.9(1,764)

1,214

1,370

＋156 ＋12.9

78

78

88

＋10 ＋12.8% of net sales

34.2

SG&A expenses% of net sales

Operating profit% of net sales

Segment profit% of net sales

43.1

Number ofpharmacies

-

37.7
33.2
4.6
4.7

YoY
change(%)

38.2
33.1
5.0
5.0

Figures in the table are rounded down
Segment profit is adjusted to ordinary profit in the consolidated statements of income.

© 2023 AIN HOLDINGS INC. All Rights Reserved.

25

FY4/24 Plan (Consolidated)
The group forecasts net sales for the fiscal year ending April 30, 2024 increase 4.5% YoY due to our plans toopen 50 dispensing pharmacies and 12 cosmetic and drugstores. Ordinary profit will decrease 4.5%（¥ million）

Net sales

316,247

358,742

375,000 ＋16,258＋4.5

Gross profit

49,971

53,69855,413＋1,715＋3.2

34,832

37,69439,750＋2,056＋5.5

15,13916,004

15,663

(341)

(2.1)

16,041

17,06416,302

(762)

(4.5)

7,092

9,234

8,250

(984)

(10.7)% of net sales

2.2

2.6

2.2

Earnings per
share(¥)

201.47262.87234.84(28.03)(10.7)

55.00

60.00

60.00

0

0.0

% of net sales

SG&A expenses% of net sales

Operating profit% of net sales

Ordinary profit% of net sales

Profit attributable toowners of parent

Annual dividend (¥)

15.8
11.0
4.8
5.1

FY4/23
results

FY4/24plan

YoYchangeFY4/22
results

15.0
10.5
4.5
4.8

YoY
change(%)

14.8
10.6
4.2
4.3

Figures in the table are rounded down
© 2023 AIN HOLDINGS INC. All Rights Reserved.

26

Inquiries related to this presentation should be addressed to

AIN HOLDINGS INC.
Corporate Planning Division
TEL(81)11-814-0010
FAX(81)11-814-5550
https://www.ainj.co.jp/
This document may not be reproduced or distributed to any third party without
prior approval of AIN HOLDINGS INC. This document has been prepared for
information purpose only and does not form part of a solicitation to sell orpurchase any securities. Information contained herein may be changed orrevised without prior notice. This document may contain forecastingstatements as to future results of operations. No forecast statement can be
guaranteed and actual results of operations may differ from those projected.

© 2023 AIN HOLDINGS INC. All Rights Reserved.

27